《美股業績》Estee Lauder母公司Tapestry(TPR)業績預測遜預期
擁有Estee Lauder、Coach及Kate Spade等品牌的Tapestry(TPR.US)公布截至7月2日止第四財季業績。季度淨利潤1.89億美元,按年跌5.5%。每股季度攤薄盈利75美仙,經調整後為78美仙,高於市場預期的77美仙。
季度淨銷售16.25億美元,按年升5.8%,差於市場預期的16.4億美元。公司季度大中華區銷售按年跌約32%,受中國新冠防疫政策影響。公司預測現財年每股盈利介乎3.8至3.9美元,低於市場預期的3.91美元。
Tapestry股價昨日(18日)低開後造好,收市升1.2%報37.57美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.